VX-659/TEZ/IVA

· Vertex Pharmaceuticals Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-659/TEZ/IVA, covering 2020-02-05 to 2020-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age [Phase 3]